Page 2 - Opgn News Today

OpGen (NASDAQ:OPGN – Get Free Report) and BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and analyst recommendations. Analyst Recommendations This is a summary of […]

StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the medical research company’s stock. OpGen Stock Performance Shares of OPGN opened at $0.38 on Friday. OpGen has a 1 year low of $0.17 and a 1 year high […]

StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a report released on Friday morning. The brokerage issued a sell rating on the medical research company’s stock. Separately, HC Wainwright lowered OpGen from a buy rating to a neutral rating in a research note on Monday, August 14th. Check Out Our Latest […]

OpGen, Inc. (NASDAQ:OPGN – Get Free Report) was the recipient of a significant decrease in short interest in the month of October. As of October 31st, there was short interest totalling 379,900 shares, a decrease of 60.1% from the October 15th total of 952,800 shares. Based on an average daily trading volume, of 4,600,000 shares, […]

StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report report published on Thursday. The firm issued a sell rating on the medical research company’s stock. Separately, HC Wainwright lowered OpGen from a buy rating to a neutral rating in a research note on Monday, August 14th. Check Out Our […]

StockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research note released on Wednesday. The brokerage issued a hold rating on the medical research company’s stock. Separately, HC Wainwright lowered OpGen from a buy rating to a neutral rating in a research report on Monday, August 14th. View Our Latest Research […]

By Colin Kellaher Shares of OpGen surged more than sixfold in premarket trading Thursday after the precision-medicine company said it was in talks on a...

StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report sent to investors on Tuesday. The brokerage issued a hold rating on the medical research company’s stock. Separately, HC Wainwright downgraded shares of OpGen from a buy rating to a neutral rating in a research report on Monday, August 14th. […]

OpGen (NASDAQ:OPGN – Get Free Report) and Aclarion (NASDAQ:ACON – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, profitability, analyst recommendations and dividends. Analyst Ratings This is a summary of recent ratings […]

StockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research note published on Sunday. The firm issued a hold rating on the medical research company’s stock. Separately, HC Wainwright cut OpGen from a buy rating to a neutral rating in a research report on Monday, August 14th. Read Our Latest Analysis […]